Not applicableNot Yet RecruitingNCT07443774
What this trial is testing
Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.
Who this might be right for
ER+ Breast CancerBreast CancerEarly Breast Cancer+3 more
University Hospital, Grenoble 81